Table 1 Patient characteristics and the incidence of different operations
From: Egyptian urinary stones in the COVID-19 outbreak: a multi-center study
Group A | Group B | p-value | ||
|---|---|---|---|---|
Age (years) median (range) | 40 (21–72) | – | ||
Sex n (%) | Total | 876 | 651 | |
Male | 594 (67.8%) | 406 (62.4%) | ?? | |
Female | 282 (32.2%) | 245 (37.62%) | ||
Stone n (%) | Total | 2684 | 2142 | 0.004 |
Yes | 786 (29.3%) | 548 (25.6%) | ||
No | 1898 (70.7%) | 1594 (74.4%) | ||
Incidence of different operations n (%) | Total | (n = 876) | (n = 651) | |
Cystolitholapaxy | 95 (10.8%) | 48 (7.4%) | 0.021 | |
PCNL + JJ | 52 (5.9%) | 49 (7.5%) | 0.216 | |
PCNL without JJ | 390 (44.5%) | 234 (35.9%) | 0.001* | |
URS without JJ | 83 (9.5%) | 161 (24.7%) | < 0.001* | |
URS + JJ | 187 (21.3%) | 139 (21.4%) | 0.998 | |
Nephrolithotomy + pyelolithotomy | 45 (5.1%) | 3 (0.5%) | < 0.001* | |
Ureterolithotomy | 7 (0.8%) | 6 (0.9%) | 0.981 | |
Cystolithotomy | 8 (0.9%) | 7 (1.1%) | 0.956 | |
Total URS | 277 (31.6%) | 301 (46.2%) | < 0.001* | |
Total PCNL | 444 (50.7%) | 285 (43.8%) | 0.008* | |